Detailed Information
Cited 20 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
BEGONIA: Phase 1b/2 study of durvalumab (D) combinations in locally advanced/metastatic triple-negative breast cancer (TNBC)-Initial results from arm 1, d+paclitaxel (P), and arm 6, d+trastuzumab deruxtecan (T-DXd).
- Authors
- Schmid, P[Schmid, Peter]; Im, SA[Im, Seock-Ah]; Armstrong, A[Armstrong, Anne]; Park, YH[Park, Yeon Hee]; Chung, WP[Chung, Wei-Pang]; Nowecki, Z[Nowecki, Zbigniew]; Lord, S[Lord, Simon]; Wysocki, PJ[Wysocki, Piotr Jan]; Lu, YS[Lu, Yen-Shen]; Dry, H[Dry, Hannah]; Karwe, V[Karwe, Vatsala]; Stewart, R[Stewart, Ross]; Herbolsheimer, P[Herbolsheimer, Pia]; Nunes, AT[Nunes, Ana Tablante]; Jung, KH[Jung, Kyung Hae]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.